Abstract：【Objective】To investigate the effect of tumor suppressor candidate 3 (TUSC3) on proliferation, migration and invasion of hepatoma cells(SMMC-7721). 【Methods】TUSC3 overexpression vector was transfected into SMMC-7721 cells, and TUSC3 mRNA and protein expression were detected by Real-time PCR and Western blot to verify the transfection efficiency of plasmid. MTT was used to detect cell proliferation at 24 h, 48 h, 72 h and 96 h after transfection. The cell migration ability was detected by wound healing and the invasion ability was detected by Transwell chamber. 【Results】TUSC3 was overexpressed in SMMC-7721 successfully. The results of MTT showed that the cell proliferation in TUSC3-overexpression group was significantly lower than that in empty vector group (P<0.01). The results of the wound healing showed that the cell migration in the TUSC3 overexpression transfection group was also significantly decreased (P<0.05). Similar to wound healing, the results of Transwell also showed that the invasive of hepatoma cells decreased after TUSC3 overexpression (P<0.01). 【Conclusion】 TUSC3 could inhibit proliferation, migration and invasion of hepatoma cells cells, and may play a tumor suppressing role in the development of hepatic carcinoma.
柯东平, 朱金祥, 毛俊倩, 刘琪, 马佳. TUSC3对人肝癌细胞增殖、迁移与侵袭的影响[J]. 医学临床研究, 2019, 36(9): 1680-1683.
KE Dong-ping, ZHU Jin-xiang, MAO Jun-qian,et al. Effect of TUSC3 on Proliferation, Migration and Invasion of Human Hepatoma Cells. JOURNAL OF CLINICAL RESEARCH, 2019, 36(9): 1680-1683.
[1] Yu X, Zhai C, Fan Y,et al. TUSC3: a novel tumour suppressor gene and its functional implications[J].J Cell Mol Med,2017,21(9):1711-1718. [2] Fan X, Zhang X, Shen J, et al. Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis[J].PLoS One,2016,11(2):e0149028. [3] Kratochvilova K, Horak P, Esner M, et al. Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells[J].Int J Cancer,2015,137(6):1330-1340. [4] Jeon YJ, Kim T, Park D, et al. miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC[J].Nat Commun,2018,9(1):5110. [5] 盛须仁, 邢松歌, 葛勇胜, 等. TUSC3基因在肝细胞癌中的表达及其临床意义[J].中国普通外科杂志, 2018, 27(1):75-80. [6] Sheng XR, Xing SG, Wang RD, et al. Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma[J].Onco Targets Ther,2018,11:909-917. [7] Vanhara P, Horak P, Pils D, et al. Loss of the oligosaccharyl transferase subunit TUSC3 promotes proliferation and migration of ovarian cancer cells[J].Int J Oncol,2013,42(4):1383-1389. [8] Vandewynckel YP, Laukens D, Geerts A, et al. The paradox of the unfolded protein response in cancer[J].Anticancer Res,2013,33(11):4683-4694. [9] Gu Y, Pei X, Ren Y, et al. Oncogenic function of TUSC3 in non-small cell lung cancer is associated with Hedgehog signalling pathway[J].Biochim Biophys Acta Mol Basis Dis,2017,1863(7):1749-1760. [10] Conway K, Edmiston SN, Tse CK, et al. Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study[J].Cancer Epidemiol Biomarkers Prev,2015,24(6):921-930. [11] Gu Y, Wang Q, Guo K, et al. TUSC3 promotes colorectal cancer progression and epithelial-mesenchymal transition (EMT) through WNT/beta-catenin and MAPK signalling[J].J Pathol,2016,239(1):60-71.
2019, Vol. 36 
